References
Treib J, Grauer MT, Woessner R, Morgenthaler M (2000) Treatment of stroke on an intensive stroke unit: a novel concept. Intensive Care Med 26: 1598–1611
Bennett CL, Davidson CJ, Raisch DW Weinberg PD, Bennett RH, Feldmann MD (1999) Thrombotic thrombocytopenic purpura associated with ticlopidine in the setting of coronary artery stents and stroke prevention. Arch Intern Med 159: 2524–2528
Schömig A, Neumann FJ, Kastrati A, Schuhlen H, Blasini R, Hadamitzky M, Walter H, Zitzmann-Roth EM, Richardt G, Alt E, Schmitt C, Ulm K (1996) A randomised comparison of antiplatelet and anticoagulation therapy after the placement of coronary artery stents. N Engl J Med 334:1084–1089
Yeh SP, Hsueh EJ, Wu H, Wang YC (1998) Ticlopidine associated plastic anemia. A case report and review of the literature. Ann Hematol 76: 87–90
Ticlid (ticlopidine HCl) [package insert] (1998) Roche Laboratories, Nutley, N.J.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zauner, C., Funk, G.C. & Birnbacher, R. Platelet aggregation inhibition with ticlopidine in the treatment of stroke. Intensive Care Med 27, 620 (2001). https://doi.org/10.1007/s001340100851
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s001340100851